Following fields are empty!
Welcome to the University of Turku Journal Guide
The Journal Guide gives you peace of mind when selecting journals. If you are a researcher from the University of Turku you can look up your favorite journals or search and filter to get to a selection of journals that match your research. Select a funder to see whether the journals are compliant or not, and check the filter ‘Journals with agreements’ to limit the list to journals for which the APCs are fully or partially waived.
Current Psychiatry
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Psychiatry Reports
Current Psychiatry Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of psychiatric disorders.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2026-2027 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.FinELib consortium’s agreement with Springer Nature for the years 2026-2027 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Springer Compact lehdissä
- Springer Nature Link Journal Finder Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen
- Instructions on publishing on FinELib's pages: Open Access Publishing in Springer Compact Journals
- Springer Nature Link Journal Finder Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you
Current Psychiatry Research and Reviews
Current Psychiatry Reviews publishes frontier review articles and guest edited issues dedicated to clinical research on all the latest advances on clinical psychiatry and its related areas e.g. pharmacology, epidemiology, clinical care and therapy. The journal is an essential reading for all clinicians, psychiatrists and researchers in psychiatry.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Psychological Reviews
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Psychology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2026-2027 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.FinELib consortium’s agreement with Springer Nature for the years 2026-2027 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Springer Compact lehdissä
- Springer Nature Link Journal Finder Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen
- Instructions on publishing on FinELib's pages: Open Access Publishing in Springer Compact Journals
- Springer Nature Link Journal Finder Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you
Current Psychopharmacology
Current Psychopharmacology publishes peer-reviewed expert full-length/mini reviews, original research articles and single topic guest edited issues on all aspects of pre-clinical and clinical research in psychopharmacology. The journal aims to be the leading forum for expert review articles in the field. The journal also accepts high-level original research articles on outstanding topics of preclinical and clinical psychopharmacology.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Pulmonology Reports
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2026-2027 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.FinELib consortium’s agreement with Springer Nature for the years 2026-2027 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Springer Compact lehdissä
- Springer Nature Link Journal Finder Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen
- Instructions on publishing on FinELib's pages: Open Access Publishing in Springer Compact Journals
- Springer Nature Link Journal Finder Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you
Current Radiology Reports
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2026-2027 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.FinELib consortium’s agreement with Springer Nature for the years 2026-2027 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Springer Compact lehdissä
- Springer Nature Link Journal Finder Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen
- Instructions on publishing on FinELib's pages: Open Access Publishing in Springer Compact Journals
- Springer Nature Link Journal Finder Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you
Current Radiopharmaceuticals
Current Radiopharmaceuticals publishes original research articles, letters, reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations. The scope of the journal covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Research Journal of Social Sciences and Humanities
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Research in Agriculture and Farming
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Research in Bacteriology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Research in Behavioural Sciences
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita sopimuskauden 2026 aikana 15 %:n alennuksella gold open access -lehtien APC-maksuista. Jos haluat hoitaa gold open access –lehdissä julkaistavien artikkelien maksuliikenteen rahoituksen yliopiston talouden kautta, liitä APC-pyyntöön talouspalvelujen ohjeistuksen mukaiset laskutustiedot: oikea laskutusosoite ja laskulle oikea maksuviite. Katso ohjeita intranetin sivulta.-
Huom! Koska avoimia artikkeleita on käytettävissä rajallinen määrä, on mahdollista, että artikkelikiintiö loppuu elo-syyskuun 2026 aikana, jonka jälkeen hyväksyttyjä artikkeleita ei välttämättä voida avata osana FinELib-sopimusta.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Elsevierin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Elsevier Journals
Under the FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles during the year 2026 with 15% discount of the journal’s APC in Elsevier gold open access journals. If you need to take care of the payment transactions through financial services of the university, please, add to your APC request invoicing information according to instructions of the financial services: correct invoicing address and reference. You can find instructions at intranet.
-
Att! Since there is a limited number of free open access articles available it is possible that the article quota is exhausted in August or September 2026.
Current Research in Biotechnology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita sopimuskauden 2026 aikana 15 %:n alennuksella gold open access -lehtien APC-maksuista. Jos haluat hoitaa gold open access –lehdissä julkaistavien artikkelien maksuliikenteen rahoituksen yliopiston talouden kautta, liitä APC-pyyntöön talouspalvelujen ohjeistuksen mukaiset laskutustiedot: oikea laskutusosoite ja laskulle oikea maksuviite. Katso ohjeita intranetin sivulta.-
Huom! Koska avoimia artikkeleita on käytettävissä rajallinen määrä, on mahdollista, että artikkelikiintiö loppuu elo-syyskuun 2026 aikana, jonka jälkeen hyväksyttyjä artikkeleita ei välttämättä voida avata osana FinELib-sopimusta.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Elsevierin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Elsevier Journals
Under the FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles during the year 2026 with 15% discount of the journal’s APC in Elsevier gold open access journals. If you need to take care of the payment transactions through financial services of the university, please, add to your APC request invoicing information according to instructions of the financial services: correct invoicing address and reference. You can find instructions at intranet.
-
Att! Since there is a limited number of free open access articles available it is possible that the article quota is exhausted in August or September 2026.
Current Research in Cell Biology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Research in Chemical Biology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Research in Dental Sciences
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Research in Dentistry
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Research in Drug Discovery
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Current Research in Ecological and Social Psychology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita sopimuskauden 2026 aikana 15 %:n alennuksella gold open access -lehtien APC-maksuista. Jos haluat hoitaa gold open access –lehdissä julkaistavien artikkelien maksuliikenteen rahoituksen yliopiston talouden kautta, liitä APC-pyyntöön talouspalvelujen ohjeistuksen mukaiset laskutustiedot: oikea laskutusosoite ja laskulle oikea maksuviite. Katso ohjeita intranetin sivulta.-
Huom! Koska avoimia artikkeleita on käytettävissä rajallinen määrä, on mahdollista, että artikkelikiintiö loppuu elo-syyskuun 2026 aikana, jonka jälkeen hyväksyttyjä artikkeleita ei välttämättä voida avata osana FinELib-sopimusta.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Elsevierin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Elsevier Journals
Under the FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles during the year 2026 with 15% discount of the journal’s APC in Elsevier gold open access journals. If you need to take care of the payment transactions through financial services of the university, please, add to your APC request invoicing information according to instructions of the financial services: correct invoicing address and reference. You can find instructions at intranet.
-
Att! Since there is a limited number of free open access articles available it is possible that the article quota is exhausted in August or September 2026.